Gimv Life Sciences Invest 2024

Antwerpen ·KBO/BCE: BE 1019.848.694

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	30-06-2026	31 d early	2026-00251313
31-03-2025	31-10-2025	25-09-2025	36 d early	2025-00507362

Metric	This company	Sector median	Position in the sector
Solvency	99.6%	43.7%	better than 95% of 514 sector peers
Net result	€-862k	€67k	better than 5% of 514 sector peers
Equity	€15.55M	€506k	better than 95% of 514 sector peers
Gross operating margin	€-159k	€81k	better than 5% of 513 sector peers
Total assets	€15.62M	€1.61M	better than 95% of 514 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€15.62M
Fixed assets	21/28	€15.53M
Financial fixed assets	28	€15.53M
Current assets	29/58	€85k
Cash & bank	54/58	€85k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€15.62M
Equity	10/15	€15.55M
Contributions / capital	10/11	€16.44M
Accumulated profits (losses)	14	€-887k
Amounts payable	17/49	€66k
Amounts payable within one year	42/48	€66k
Trade debts payable within one year	44	€57k
Income statement
Gross operating margin	9900	€-159k
Operating result	9901	€-214k
Financial income	75	€4k
Financial charges	65	€2k
Result before taxes	9903	€-862k
Net result for the period	9904	€-862k
Result to be appropriated	9905	€-862k

Summary